Patent · US Active

Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones

US9932323B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

Rutgers, the State University of New Jersey · US

Inventors

Edmond J. LaVoie · Princeton Junction, US
Joseph David Bauman · New Brunswick, US
Ajit Parhi · New Brunswick, US
Hye Yeon Sagong · New Brunswick, US
Disha Patel · New Brunswick, US
Eddy Arnold · New Brunswick, US
Kalyan Das · Edison, US
Suyambu Kesava Vijayan · New Brunswick, US

Key dates

Filing date	Jan 13, 2017
Grant date	Apr 3, 2018
Priority date	—
Expiry date	Jan 13, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention provides compounds of formula I:and salts and prodrugs thereof wherein R4, X1 and X2 have any of the meanings defined in the specification, as well as pharmaceutical compositions comprising the compounds or salts and methods for their use in therapy. The compounds have useful antiviral properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.